Fulvestrant Farmalan

Fulvestrant Farmalan is an intramuscular injection used for hormone receptor-positive breast cancer treatment. This medication is designed to block estrogen receptors, helping to slow the progression of certain types of cancer. It is manufactured by Laboratorios Farmalán in the EU.

Fulvestrant Farmalan is primarily used in the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women. It works by binding to estrogen receptors, which can help inhibit the growth of cancer cells. This medication is often considered for patients who have progressed after other hormone therapies. What is Fulvestrant used for? It is typically prescribed for advanced breast cancer that has spread to other parts of the body.

Common effects of Fulvestrant Farmalan may include injection site reactions, such as pain, swelling, or redness. Some patients may also experience fatigue, nausea, or headaches. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Fulvestrant Farmalan should be administered by a healthcare professional to ensure proper intramuscular injection. It is important to follow all safety guidelines provided by the manufacturer. Patients should inform their healthcare provider about any allergies or medical conditions before starting this treatment.

Fulvestrant Farmalan may interact with other medications, including those that affect liver enzymes. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of this medication.